Matrine can down-regulate M3 receptor-activated delayed rectifier K+ current (IKM3) density as well as M3 receptor expression, up-regulate ICa-L density and α1C/Cav1.2 expression, reduce AF incidence, and decrease AF duration (88). The gene discussed is CACNA1C; the disease is atrial fibrillation.